XNASUFPT
Market cap1.86bUSD
Jan 10, Last price
241.95USD
1D
-3.63%
1Q
-22.64%
Jan 2017
850.69%
Name
UFP Technologies Inc
Chart & Performance
Profile
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 400,072 13.08% | 353,792 71.48% | |||||||
Cost of revenue | 295,047 | 272,832 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 105,025 | 80,960 | |||||||
NOPBT Margin | 26.25% | 22.88% | |||||||
Operating Taxes | 8,978 | 10,929 | |||||||
Tax Rate | 8.55% | 13.50% | |||||||
NOPAT | 96,047 | 70,031 | |||||||
Net income | 44,924 7.50% | 41,789 163.06% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (2,641) | (1,288) | |||||||
BB yield | 0.20% | 0.14% | |||||||
Debt | |||||||||
Debt current | 10,444 | 4,000 | |||||||
Long-term debt | 52,852 | 64,368 | |||||||
Deferred revenue | 448 | ||||||||
Other long-term liabilities | 20,593 | 32,342 | |||||||
Net debt | 58,033 | 63,917 | |||||||
Cash flow | |||||||||
Cash from operating activities | 41,334 | 17,744 | |||||||
CAPEX | (10,490) | (13,780) | |||||||
Cash from investing activities | (10,488) | 1,291 | |||||||
Cash from financing activities | (30,024) | (25,894) | |||||||
FCF | 45,626 | 65,454 | |||||||
Balance | |||||||||
Cash | 5,263 | 4,451 | |||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | 247,864 | 202,062 | |||||||
Invested Capital | 355,943 | 323,653 | |||||||
ROIC | 28.27% | 22.40% | |||||||
ROCE | 29.47% | 24.98% | |||||||
EV | |||||||||
Common stock shares outstanding | 7,701 | 7,663 | |||||||
Price | 172.04 45.93% | 117.89 67.79% | |||||||
Market cap | 1,324,880 46.66% | 903,391 68.85% | |||||||
EV | 1,382,913 | 967,308 | |||||||
EBITDA | 116,432 | 92,846 | |||||||
EV/EBITDA | 11.88 | 10.42 | |||||||
Interest | 3,645 | 2,763 | |||||||
Interest/NOPBT | 3.47% | 3.41% |